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Dialysis patients suffer excess heart failure, present in 
up‑to 33%, associated with high mortality; and high sudden 
cardiac death rates, 6.5% per year; mostly due to coronary 
artery disease and autonomic dysfunction.[1] Left ventricular 
cardiomyopathy and hypertrophy have been well described 
in dialysis patients[2] but specific descriptions of Takotsubo 
syndrome (TS) in this population are rare, with only a 
few case studies, as described in manuscript in the present 
issue of journal.[3] This is perhaps suggestive of the fact 
that TS, as a cause of chest pain or heart failure in the 
dialysis population, will be far less common than that 
caused by coronary artery disease (CAD), a leading cause 
of death in chronic kidney disease (CKD) and dialysis 
patients.[1] Previous studies have suggested CKD as a 
risk factor in patients with TS. A systematic review of 
1109 patients quoted that CKD was present in 7% (range 
2‑27%).[4] TS has been described in acute kidney injury, 
CKD, kidney‑transplantation, haemodialysis and peritoneal 
dialysis patients. However, there are no prospective cohort 
studies in dialysis patients and hence exact incidence, 
prognosis and causative mechanism are unknown.[5]
Clinical Characteristics of Takotsubo’s 
Cardiomyopathy, Diagnosis in Dialysis Patients
TS is a diagnosis of exclusion, described in post‑menopausal 
females, often precipitated by emotional and physical stress. 
As suggested by the ‘International Takotsubo Diagnostic 
Criteria’, diagnosis of TS hinges on a specific set of 
results seen from investigations including serial troponins, 
electrocardiograms, echocardiogram and coronary 
angiography.[6] The reversibility of the specific changes as 
well as the absence of culprit atherosclerotic disease is the 
key to a correct diagnosis. A patient presenting with acute 
chest pain on dialysis will require prompt investigations 
to rule out the more likely diagnosis of acute coronary 
ischaemia; as described in the case report. Whilst making 
a timely diagnosis of TS is important, the initial focus 
should be to ensure there is no cardiac ischaemia requiring 
immediate treatment in this high‑risk population. It is 
particularly important to differentiate between TS and CAD 
in patient with cardiogenic shock due to the possible harm 
with the use of certain inotropes in TS.[7]
Mechanism of Takotsubo’s Syndrome
The prevalent catecholamine theory for TS, as outlined in 
the accompanying article, is supported by the specific cardiac 
dysfunction seen following a sudden sympathetic surge 
with depression of parasympathetic activity.[7] However, 
catecholamine release and response in a dialysis patient may 
well be different from the non‑dialysis population. Substantial 
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evidence exists demonstrating the sustained heightened 
sympathetic tone with suppressed parasympathetic tone in 
dialysis patients.[8] It is unclear whether the acute stressor 
event triggering a decline in myocyte contractility seen in 
TS would be triggered in a cohort of patients with already 
chronically heightened catecholamine levels.
The trigger mentioned in most literature is usually an 
acute emotional event, hence the “broken heart” syndrome 
label. However, in the accompanying article, there was 
no single precipitating event. It seems unlikely that the 
chronic emotional stress associated with living with a 
chronic condition, in this case renal failure, has the same 
biochemical response as the acute events described that 
result in the high catecholamine release.
Intradialytic Myocardial Stunning and Takotsubo 
Syndrome
Previous studies have described repeat episodes of 
myocardial dysfunction during dialysis shown by 
echocardiogram and other imaging modalities. Such 
episodes may happen due to excess myocardial oxygen 
demand during dialysis, necessary to maintain higher 
cardiac output, in the presence of stable CAD. The 
‘demand myocardial ischaemia’ occurring during dialysis 
patients causes temporary left ventricular remodelling or 
myocardial stunning, which reverses post‑dialysis and its 
long‑term effects are unknown. These changes have been 
compared to TS.[9] However, the mechanism of intradialytic 
myocardial dysfunction is likely to be due to ischaemia and 
different from mechanism of TS, i.e. sudden sympathetic 
surge, though sympathetic overactivity during dialysis may 
happen. Moreover, intradialytic myocardial stunning is 
common, happens repeatedly, but TS is rarely reported in 
dialysis patients. Though very rare, TS has been reported 
in peritoneal dialysis patients, and it may be interesting 
to compare the incidence and nature of TS in peritoneal 
dialysis patients compared to haemodialysis patients. 
Such a comparison may generate new ideas for possible 
mechanism of TS in CKD and ESRD patients.
Other Reversible Causes of Heart Failure in Dialysis
There may other causes of reversible congestive heart failure 
in dialysis patients, such as coronary spasm and transient 
coronary artery occlusion due to a clot which disintegrates 
rapidly and not seen on angiography. Such cases may be 
misinterpreted as sympathetic surge related TS.
Conclusion
Takotsubo syndrome (TS) is a sudden, severe cardiac 
dysfunction with chest pain, precipitated by stress. It is 
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reversible in nature but often difficult to diagnose and rarely 
reported in dialysis; the mechanism of which is largely 
unknown. Dialysis patients with significant autonomic 
dysfunction, which makes them more prone to sudden cardiac 
arrhythmias, may be at risk. However, raising awareness 
of this condition among dialysis physicians is necessary 
to establish the diagnosis in dialysis patients and better 
understand the mechanism causing this devastating illness.
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